tiprankstipranks
Curis reports Q1 EPS ($2.05), consensus ($2.12)
PremiumThe FlyCuris reports Q1 EPS ($2.05), consensus ($2.12)
11d ago
Two new option listings and  option delistings on March 25th
PremiumThe Fly
Two new option listings and option delistings on March 25th
2M ago
Truist biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Truist biotech analysts hold an analyst/industry conference call
3M ago
Curis files $300M common stock offering
PremiumThe FlyCuris files $300M common stock offering
3M ago
Curis sees cash, cash equivalents and investments sufficient into 2025
PremiumThe Fly
Curis sees cash, cash equivalents and investments sufficient into 2025
3M ago
Curis reports Q4 EPS ($2.03), consensus ($2.11)
PremiumThe Fly
Curis reports Q4 EPS ($2.03), consensus ($2.11)
3M ago
Curis’ licensed emavusertib shows efficacy in lymphoma trial
PremiumThe FlyCuris’ licensed emavusertib shows efficacy in lymphoma trial
5M ago
Curis presented data from the TakeAim Leukemia study at 2023 ASH conference
PremiumThe Fly
Curis presented data from the TakeAim Leukemia study at 2023 ASH conference
5M ago
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100